CONSORT diagram illustrating patient flow during the study. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups. by Anneli Peolsson (7867601)

Subjects:

Outcomes in DHI score, dizziness and unsteadiness at baseline and at three- and 15-month follow-ups for each WAD group, and within-group effects. by Anneli Peolsson (7867601)

Subjects:

Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline descriptive characteristics of trial participants with dizziness, by treatment group. by Anneli Peolsson (7867601)

Subjects:

Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and t... by Anneli Peolsson (7867601)

Subjects:

Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Variables obtained from the SF-36 quality of life questionnaire in each experimental group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Line graph showing the values of myocardial perfusion defects in the study groups. p = ANOVA Mixed Models. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Outcomes in DHI score, dizziness and unsteadiness at baseline and at three- and 15-month follow-ups for each intervention group, and within-group effects. by Anneli Peolsson (7867601)

Subjects:

NMN improves neurological function and survival after cardiac arrest in mice. by Daiki Kaito (12514087)

Baseline characteristics of the participants. by Jia Song (495396)

“…</p><p>Results</p><p>After finerenone treatment, the levels of UACR, urinary β2-microglobulin (β2-MG) and proinflammatory cytokines in patients decreased compared with the pretreatment levels. Moreover, the rates of decrease in the UACR levels in the macroalbuminuria group were significantly greater than those in the microalbuminuria group. …”

GLM models for predictors of monthly HIV costs. by Drew B. Cameron (10687420)

“…</p><p>Conclusions</p><p>Patient out of pocket costs of care for HIV and HTN were substantial, but significantly lower during the 2021 full COVID-19 lockdown in Uganda. …”

Median cost (USD) per visit breakdown. by Drew B. Cameron (10687420)

“…</p><p>Conclusions</p><p>Patient out of pocket costs of care for HIV and HTN were substantial, but significantly lower during the 2021 full COVID-19 lockdown in Uganda. …”

Flow of selecting the study participants. by Kazuhiro Suzuki (160528)

Subjects:

P–P and Q–Q plots for assessing normality of residuals. by Kazuhiro Suzuki (160528)

Subjects: